Anthera Pharmaceuticals (OTCMKTS:ANTH) Share Price Passes Above 200-Day Moving Average – What’s Next?

Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 774 shares trading hands.

Anthera Pharmaceuticals Stock Performance

Get Anthera Pharmaceuticals alerts:

Anthera Pharmaceuticals Company Profile

(Get Free Report)

Anthera Pharmaceuticals, trading on the OTC Markets under the symbol ANTH, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for patients suffering from serious and rare inflammatory and autoimmune diseases. The company’s research and development efforts center on both biologic and small-molecule approaches designed to modulate key pathways in immune system dysfunction. Anthera’s strategy includes advancing lead candidates through late-stage clinical trials while exploring additional indications for its pipeline assets.

The company’s most advanced asset, blisibimod, is a selective antagonist of B-cell activating factor (BAFF) that has been evaluated in clinical studies for systemic lupus erythematosus (SLE) and primary immune thrombocytopenia (ITP).

Featured Articles

• Five stocks we like better than Anthera Pharmaceuticals
• Time to Sell? 3 Winners With Fading Technical Momentum
• Why These 2 Hotel Stocks Are Beating Travel Peers
• This Energy Stock Has Quietly Soared 130% in a Year
• 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups

Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.